Climb Bio Inc (CLYM)

Profile

Company profile for Climb Bio Inc (CLYM)
MetricValue
Full NameClimb Bio Inc
TickerNASDAQ: CLYM
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
IndexesNot included
Websiteclimbbio.com
Employees17

Key Metrics

Climb Bio Inc Key Details
MetricDateValue
Price$4.58
Price, 1D Change+9.05%
$312M
-
-
0.98
$0
Revenue, 1Y Change0.00%
-$1.53
EPS, 1Y Change-17.91%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Climb Bio Inc chart

Events

Climb Bio Inc Events
MetricDateValue
Next EarningsN/A
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeELYM
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

CLYM Estimates
MetricDateValue
-$1.53
EPS EstimateN/A-$0.81
EPS Est. ChangeN/A+47.21%
$0.00
Revenue EstimateN/A-
Revenue Est. ChangeN/A-
Current Price$4.58
Price Target-$9.50
Price Tgt. Change-+107.42%

🔒 Log In To Unlock Full Data

EPS

CLYM EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$0.81N/A-
-$0.81N/A-
CLYM EPS reported versus estimate values chart

Revenue

CLYM revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
-N/A-
-N/A-
CLYM revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

CLYM Performance
MetricDateValue
Price, 1Y+144.92%
Price, 3Y-1.29%
+148.30%
+153.33%
0.00%
0.00%
-17.91%
+22.63%

🔒 Log In To Unlock Full Data

Technical Indicators

CLYM Technical Indicators
MetricDateValue
Current Price$4.58
$1.88
SMA 200 vs Price-58.96%
$2.72
SMA 50 vs Price-40.52%
0.98
$0.45
64.10
122.01%
93.26%

Dividends

CLYM Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
$0.00
0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

CLYM Income & Profitability
MetricDateValue
$0.00
-$1.53
$0.00
-
-$30.36M
-
-$73.90M
-
-$30.36M

🔒 Log In To Unlock Full Data

Financial Health

CLYM Financial Health
MetricDateValue
0.00
31.41
31.41
-
-
34.20

Valuations

CLYM Valuations
MetricDateValue
-
-
1.76
-3.80
N/A-

Balance Sheet

CLYM Balance Sheet
MetricDateValue
$211.88M
$87.23M
$217.19M
$154.87M
$5.31M
$4.93M
$532.00K
$157.00K
$705.00K

Expenses

CLYM Expenses
MetricDateValue
$30.36M
$30.36M
$0.00
$16.03M
-
$0.00
$0.00

Cash Flow

CLYM Cash Flow
MetricDateValue
-$15.56M
-$121.09M
$130.73M
$0.00
-$15.56M

Recent analyst updates

CLYM Recent analyst updates
MetricDateValue
HC Wainwright & Co.
William Blair
BTIG
HC Wainwright & Co.
BTIG
BTIG
Baird
Oppenheimer

Analyst sentiment

Sentiment over the past month
CLYM analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
CLYM institutional ownership distribution chart

Screeners with CLYM

Data Sources & References

  1. CLYM Official Website climbbio.com
  2. CLYM Profile on Yahoo Finance finance.yahoo.com/quote/CLYM
  3. CLYM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/clym

FAQ

  • What is the ticker symbol for Climb Bio Inc?

    The ticker symbol for Climb Bio Inc is NASDAQ:CLYM

  • Does Climb Bio Inc pay dividends?

    No, Climb Bio Inc does not pay dividends

  • What sector is Climb Bio Inc in?

    Climb Bio Inc is in the Healthcare sector

  • What industry is Climb Bio Inc in?

    Climb Bio Inc is in the Biotechnology industry

  • What country is Climb Bio Inc based in?

    Climb Bio Inc is headquartered in United States

  • When did Climb Bio Inc go public?

    Climb Bio Inc initial public offering (IPO) was on August 10, 2021

  • Is Climb Bio Inc in the S&P 500?

    No, Climb Bio Inc is not included in the S&P 500 index

  • Is Climb Bio Inc in the NASDAQ 100?

    No, Climb Bio Inc is not included in the NASDAQ 100 index

  • Is Climb Bio Inc in the Dow Jones?

    No, Climb Bio Inc is not included in the Dow Jones index

  • When was Climb Bio Inc last earnings report?

    Climb Bio Inc's most recent earnings report was on August 14, 2025

  • When does Climb Bio Inc report earnings?

    The date for Climb Bio Inc's next earnings report has not been announced yet